Blood sample: Clinical Trials

11 trials of Blood sample, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 2 withdrawn, 1 recruiting. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 5, Active not recruiting 2, Withdrawn 2, Recruiting 1, Terminated 1
Phase 22Active not recruiting 1, Withdrawn 1

Follow Blood sample: new trials by email Literature Review of Blood sample trials Research Report on Blood sample

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer
quality of life questionnaires, Blood sample, Regorafenib - Metastatic Colorectal Cancer
Phase 2 / Phase 3Active not recruitingCentre Hospitalier Universitaire de Besancon4462023-05-092026-11-04
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol
Blood sample, Urine sample, Saliva sample - Systemic Lupus Erythematosus (SLE)
Phase 3Active not recruitingUniversity Hospital, Brest252022-11-292026-06-26
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
AZA capsules, MTX, blood sample - Crohn Disease, Azathioprine
Phase 3RecruitingCentre Hospitalier Universitaire, Amiens1662021-08-262025-05-28
Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49
Meningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine, Blood sample - Meningococcal Infection (Healthy Volunteers)
Phase 3CompletedSanofi Pasteur, a Sanofi Company4712019-10-042025-09-11
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
Blood Sample - Hepatitis B, Pertussis
Phase 3CompletedMCM Vaccines B.V.7542016-04-262020-06-09
Postoperative REcurrence and DynamICs of T Cell Subsets in Crohn's Disease
blood sample - Crohn Disease
Phase 3CompletedHospices Civils de Lyon592011-01-012025-12-04
Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers
Blood sample, JE-CV administered in Study JEC02 - Encephalitis, Japanese Encephalitis
Phase 3CompletedSanofi Pasteur, a Sanofi Company5962009-08-072017-11-29
New Treatment for Donor Sites
Application of donor site dressing [scarlet red, Microbial Nanocellulose (NC), or hyaluronan and thrombin (HT)], Blood sample, Biopsy - Burn
Phase 2 / Phase 3WithdrawnThe University of Texas Medical Branch, Galveston2006-01-012012-12-11
Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
loxapine, midazolam, blood sample, patient monitoring - Acute Agitated Patients
Phase 3TerminatedUniversity Hospital, Rouen1202005-12-012015-03-11
HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population
blood sample - Diabetes Mellitus Type 2, Proliferative Diabetic Retinopathy
Phase 3WithdrawnAsociación para Evitar la Ceguera en México2004-09-012024-06-03
Transition Study: Growth Hormone Therapy In Partial Growth Hormone Deficient Adolescents
Blood sample, Radiography - Growth Hormone Deficiency
Phase 3CompletedPfizer902002-04-012007-07-30

Conditions studied

Crohn Disease (2)  ·  Burns (1)  ·  Cicatrix (1)  ·  Colorectal Neoplasms (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Dwarfism, Pituitary (1)  ·  Emergencies (1)  ·  Encephalitis (1)  ·  Encephalitis, Japanese (1)  ·  Hepatitis B (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Meningococcal Infections (1)  ·  Psychomotor Agitation (1)  ·  Whooping Cough (1)

Sponsors

Sanofi Pasteur, a Sanofi Company (2)  ·  Asociación para Evitar la Ceguera en México (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Hospices Civils de Lyon (1)  ·  MCM Vaccines B.V. (1)  ·  Pfizer (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University Hospital, Brest (1)  ·  University Hospital, Rouen (1)

Countries

France (5)  ·  Mexico (1)  ·  Philippines (1)  ·  Puerto Rico (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

David N Herndon, MD (1)  ·  Fabienne FM Moritz, MD (1)  ·  Hugo Quiroz-Mercado, MD (1)

Results publications

PMID 26589954, PMID 31689166, PMID 36632042, PMID 39555800

NIH funding

2016 (1)